PLTR enters the post-earnings week with a familiar problem: results that impressed on fundamentals but unnerved investors on valuation.
The stock fell 5.7% on May 5 following Monday's Q1 print, extending a month-long decline to roughly 8.5% and leaving the stock at $135.91. That reaction — a beat followed by a sell — is the central tension for Palantir right now. The business appears to be executing. The price was already pricing that in and then some.
The post-earnings analyst response captures the split almost perfectly. Bulls moved fast and decisively. Citigroup's Tyler Radke raised his target to $225 on May 6, up from $210 just weeks after he'd already cut it from $260. Argus Research upgraded outright to Buy with a $190 target on the same day. Wedbush held its $230 Outperform, and Rosenblatt lifted to $225. Against that, RBC Capital's Rishi Jaluria stood firm at Underperform and a $90 target — a view sitting more than 30% below where the stock currently trades. DA Davidson trimmed its Neutral target to $165 from $180. And last week, HSBC downgraded to Hold from Buy, cutting its target to $151 from $205 — the most aggressive directional move in recent weeks. The mean price target across the Street runs close to $185, implying roughly 36% upside to the current price. The spread between the bull and bear camp is unusually wide, and both sides can find the data they're looking for.
The bull case rests on growth momentum. EPS momentum ranks in the 93rd percentile on a 30-day basis and 82nd percentile over 90 days. The company reported 137% year-over-year commercial revenue growth in Q4 2025, and the $185 billion Golden Dome contract has given the government segment a headline number to wave at skeptics. Bears point to concentration risk — a handful of large contracts dominate revenue — and to a valuation that demands perfection. The P/E multiple runs at roughly 83x, and EV/EBITDA near 60x, both of which have compressed meaningfully over the past 30 days as the stock has pulled back. The EV/EBITDA multiple is down more than 12 points over the month. That multiple compression may be why bulls are seeing a better entry — but the bear view is that compression still has further to go.
Short positioning has ticked higher after the earnings reaction, though the overall level remains modest. SI % FF climbed to 2.55% on May 5, up from 2.29% a month ago — a steady grind rather than an aggressive bet. The borrow market reflects that: cost to borrow is running at a very low 0.38%, and the lending pool remains extremely loose, well above any threshold that would suggest squeeze pressure. Short availability has not tightened at any meaningful level. This is not a stock where shorts are stretched or crowded — the incremental rise in SI looks more like tactical hedging after the earnings drop than a fundamental conviction trade. The ORTEX short score of 30.4 (out of 100) confirms the same: bearish pressure exists but is not building to an extreme.
Options positioning reinforces the cautious but not panicked read. The put/call ratio is running at 1.07, almost exactly in line with its 20-day average of 1.08, and the z-score of -0.22 signals no meaningful deviation from recent norms. At the 52-week level, the PCR has ranged from 0.61 to 1.16 — the current reading places it in the upper half of that range, consistent with a market that's hedging but not alarmed. Peer context adds colour: APP gained 6.5% on the week and CRWD rose 4.7%, while PLTR fell 3.7%. The divergence suggests the post-earnings selling was stock-specific rather than a sector-wide rotation.
Ownership data carries one notable detail. Co-founder Peter Thiel trimmed his position by 2 million shares as of early April. CEO Alexander Karp added modestly — roughly 482,000 shares — over the same period. These are large pools relative to insider data, but the net 90-day figure across all insiders runs to a positive 2.67 million shares, suggesting selling has not dominated at the company level. Director Alex Moore conducted a series of scheduled sales at prices in the $135–$153 range during March and April, all at low significance scores, consistent with a pre-planned trading programme.
With next earnings set for June 3, the question is whether six weeks is enough time for the valuation re-rating debate to settle. The business fundamentals scores — EPS momentum, EPS surprise — sit in the top quartile of the universe. The valuation scores, by contrast, rank near the bottom, with the EV/EBIT factor in the 4th percentile. That is the tension the June print will either widen or begin to close.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.